Epithelial Ovarian Cancer - Epidemiology Forecast to 2027

Epithelial Ovarian Cancer - Epidemiology Forecast to 2027

  • January 2018 •
  • 50 pages •
  • Report ID: 5299520
DelveInsight’s "Epithelial Ovarian Cancer - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Epithelial Ovarian Cancer epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Epithelial Ovarian Cancer Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Epithelial Ovarian Cancer in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Epithelial Ovarian Cancer outlook. It also includes the explanation of changing trends of epidemiology outlining the Epithelial Ovarian Cancer scenario.

Epithelial Ovarian Cancer Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Epithelial Ovarian Cancer thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Epithelial Ovarian Cancer explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Epithelial Ovarian Cancer Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Epithelial Ovarian Cancer

Key assessments
• Patient Segmentation in Epithelial Ovarian Cancer
• Epithelial Ovarian Cancer Risk & Burden
• Factors driving growth in a specific Epithelial Ovarian Cancer patient population